Retrospective study finds no cases of topical steroid withdrawal from corticosteroid therapy in vulval lichen sclerosus, indicating insufficient evidence that withdrawal syndrome is a risk.
Retrospective study in New Zealand reviewing the incidence of topical steroid withdrawal (TSW) and other adverse effects related to topical corticosteroid (TCS) use in vulval lichen sclerosus (VLS). No patients experienced TSW and majority of patients did not experience any adverse effects. There is insufficient evidence to conclude that TSW is a potential adverse effect of long term TCS use for VLS.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: